Tilray | TRLY - Des Atouts





Des Atouts Changement Date
Acasti Pharma USD 68.49M 1.91M 2025-12
Akebia Therapeutics USD 349.66M 12.86M 2026-06
Alaunos Therapeutics USD 1.88M 1.08M 2026-03
Aurora Cannabis CAD 601.09M 174.2M 2026-03
Avita Medical AUD 56.39M 1.74M 2025-12
Canopy Growth CAD 1.12B 12.54M 2026-03
Cronos Group USD 1.18B 7.75M 2026-06
Dianthus Therapeutics USD 1.21B 33.61M 2026-06
Divis Laboratories Ltd INR 200.33B 18.82B 2026-03
Ionis Pharmaceuticals USD 2.99B 455.5M 2026-06
IQVIA Holdings USD 29.88B 206M 2026-06
Knight Therapeutics CAD 1.05B 2.28M 2025-12
Moderna USD 10.96B 527M 2026-06
Organigram Holdings CAD 521.31M 9.36M 2026-03
Organon & Co USD 13.18B 182M 2026-06
Revvity USD 12.05B 49.24M 2026-06
Tectonic Therapeutic USD 246.58M 14.46M 2026-03
Tilray USD 2.1B 15.95M 2025-09
Viatris USD 35.04B 1.79B 2026-06
Xeris Pharmaceuticals USD 411.9M 19.89M 2026-06
Zealand Pharma A/S 15.3B 647.8M 2026-03